A phase 1 study of FluBHPVE6E7 immunotherapy in patients with HPV16-associated oropharyngeal squamous cell carcinoma
Phase 1
Active, not recruiting
- Conditions
- MedDRA version: 20.1Level: LLTClassification code: 10063001Term: Human papilloma virus infection Class: 10021881Treatment of human papilloma virus (HPV) associated infections and cancersTherapeutic area: Diseases [C] - Virus Diseases [C02]Therapeutic area: Diseases [C] - Otorhinolaryngologic Diseases [C09]
- Registration Number
- CTIS2024-514413-36-00
- Lead Sponsor
- Bluesky Immunotherapies GmbH
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Not Recruiting
- Sex
- All
- Target Recruitment
- 12
Inclusion Criteria
Not provided
Exclusion Criteria
Not provided
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method